The analgesic effect of barley tea (Hordeum vulgare L.) on patients with migraine headaches

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220818055740N4

Enrollment

Registered

2023-05-29

Start date

2017-09-01

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Headaches. Specific personality disorders

Interventions

Intervention 1: Intervention group: Patients who receive routine treatment with barley tea. Intervention 2: Control group: Patients who receive routine treatment.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were including the person's consent to participate in the study, not having dependent on alcohol or narcotic drugs and not having a history of cognitive impairment, not taking long-term sedatives and other psychiatric drugs

Exclusion criteria

Exclusion criteria: Suffering from diabetes or any other underlying disease, having a history of allergy to aromatic substances, and having a proven problem with the sense of smell.

Design outcomes

Primary

Measure	Time frame
The rate of pain intensity for headache after intervention. Timepoint: 6 weeks performed intervention. then, The rate of pain intensify was measured. Method of measurement: Standard Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahid Jivad

Shahre-kord University of Medical Sciences

Jivad@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026